Author Archives: James Carroll

About James Carroll

Founder and CEO at THOR Photomedicine Ltd. View biography (PDF)

PBM Therapy Literature Watch January 2018

27 Photobiomodulation therapy papers published in January 2018. Highlights include:

  • Treatment 6h before + immediately before exercise best for reducing muscle fatigue
  • Review of pre-clinical data for dementia, Parkinson’s, stroke, trauma and depression
  • Improved bacteriological, cytological and clinical benefits after root planing (RCT)
  • Improved wound healing of skin graft donor site (RCT)
  • Systematic review of RCTs on  LED PBM therapy in dermatology
  • NSAIDs vs PBM Therapy post root canal (RCT)
  • ESWT vs PBM Therapy for Plantar Fasciitis (RCT)
  • Effect of PBM on cerebral hemodynamics and metabolism are not thermal
Posted in Research | Leave a comment

Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy

National Institute for Health and Care Excellence (NICE)
RESULT: After three presentations and much correspondence over a 5 year period we have a recommendation guideline from the National Institute of Health and Care Excellence (NICE) — LLLT for preventing or treating oral mucositis caused by radiotherapy or chemotherapy. This means the NHS can start using our treatment on cancer patients to reduce some of the painful side effects of cancer treatments.

Read here: https://www.nice.org.uk/guidance/ipg615

Posted in Industry | 1 Comment

LumiThera Presents LIGHTSITE I Dry AMD Top Line Final Data

The LT-300 LED ophthalmologic instrument station provides a multi-wavelength approach to treating ocular disease.The LIGHTSITE I data was presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) annual conference by Marion Munk, MD, PhD, Department of Ophthalmology/Bern Photographic Reading Center and Managing Director, Bern Photographic Reading Center, University Hospital Bern. Dr. Munk was part of the investigator team.

“LumiThera PBM treatment demonstrated reductions in central drusen volume over the course of the one-year study versus the sham treatment with statistical significance at one year, (p = 0.05). Drusen is the hallmark pathology of dry AMD and is an important proinflammatory mediator and marker for disease progression,” says Dr. … Continue reading

Posted in Industry | Leave a comment

LumiThera Named Most Innovative And Promising Medtech & E-Health Company At Biovision 2017

The LT-300 LED ophthalmologic instrument station provides a multi-wavelength approach to treating ocular disease.LumiThera® Inc., a clinical stage medical device company focused on delivering non-invasive photobiomodulation (PBM) therapies for ocular disorders and disease, today announced it has been awarded the prestigious “MOST INNOVATIVE AND PROMISING MEDTECH & E-HEALTH COMPANY” during Biovision 2017 in Lyon, France.

This is great news for patients suffering from dry AMD who have no other treatment alternatives!

Read the full press release:
LumiThera Named Most Innovative And Promising Medtech & E-Health Company At Biovision 2017

Disclosure: I am an investor in Lumithera a) because it successfully treats an unmet medical need, (dry AMD) b) I … Continue reading

Posted in Industry | 2 Comments

The story of how LLLT / Photobiomodulation was discovered

This is an extraordinary lecture. It is the story of how LLLT / Photobiomodulation was discovered, and because of the context in which it occurred you might also find it very moving, so get some tissues. It is an hour and 10 minutes long so get comfortable, maybe get some popcorn and a drink too. I will paste the email that Andrew Mester wrote into the comments section below.

Here is the email from Andrew Mester :

I had the privilege to give a keynote presentation at the most recent NAALT (North American Association of PhotobiomoduLation Therapy) meeting in February 5, 2017 in Coronado Island, San Diego. The title of paper was: “Invention of … Continue reading

Posted in Conference, Interviews, Special Feature | Leave a comment

LLLT / Photobiomodulation cures acute thrombocytopenia in mice

Zhang et al showed that whole body 810nm laser 100mW/cm2, 30J/cm2 cures acute thrombocytopenia in mice.

Thrombocytopenia is a common hematologic disorder that is managed primarily by platelet transfusions. They showed that noninvasive whole-body illumination cures acute thrombocytopenia triggered by g-irradiation within 2 weeks in mice, as opposed to a 5-week recovery time required in controls.

The low-level laser (LLL) also greatly accelerated platelet regeneration in the presence of anti-CD41 antibody that binds and depletes platelets, and prevented a severe drop in platelet count caused by a common chemo-therapeutic drug.

They conclude: this safe, drug-free, donor-independent modality represents a paradigm shift in the prophylaxis and treatment of thrombocytopenia.

Full abstract and paper here http://stm.sciencemag.org/content/8/349/349ra101

As you know … Continue reading

Posted in Research | Leave a comment

New Book: The Truth About Chronic Pain Treatments

The Best and Worst Strategies for Becoming Pain Free

The Truth About Chronic Pain Treatments: The Best and Worst Strategies for Becoming Pain Free
A well researched and unbiased book/resource by Cindy Perlin for people in chronic pain that are not getting adequate relief from their treatment. The book is evidence-based and examines 14 different categories of treatment (including Photobiomodulation – LLLT).

The Truth About Chronic Pain Treatments reviews the evidence for the safety and effectiveness of a wide variety of treatments, and reveals how organized medicine may be keeping you from getting the care you need and deserve.

Continue reading

Posted in Books and Journals | Leave a comment

Laser Treatment Halts Oral Mucositis in Its Tracks

Published article by Fran Lowry on Medscape. May 01, 2015.

Spa-like treatment with a cool, low-level laser, similar to that use for wrinkles, vanquishes oral mucositis, one of the most debilitating toxicities of cancer therapy.

“I have been an oncology nurse for over 25 years, and in those 25 years, there has been nothing that helps prevent or is effective against the treatment for oral mucositis, until now,” said Annette Quinn, RN, MSN, from the University of Pittsburgh Cancer Institute.

“Patients say they rank it higher than nausea and vomiting when it comes to adverse side effects, especially because we have good medications to control nausea and vomiting. But the low-level laser works better than we could have hoped,” Quinn … Continue reading

Posted in Research | Leave a comment